Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP

Read more

PHARMAP 2024 held in Amsterdam, marks its fourth edition

Read more

Research led by Sydney University develop nanotech-based oral insulin medicine

Read more

Chinese companies lead ADC development pipeline: GlobalData

Read more

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility

Read more

Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR alterations

Read more

Lupin launches biosimilar Etanercept in Canada

Read more

DP World establishes new warehouse in Goa

Read more

Naprod renews EU-GMP certification for Palghar facility

Read more

Emcure unveils campaign ‘Cure and Beyond’

Read more